Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients

Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients

Conclusion: Our study suggests that telomere length in cfDNA may be a useful biomarker for predicting therapy response and possible reoccurrence of the disease in breast cancer patients.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	İrem Peker Eyüboğlu, Sinan Koca, Betül Çelik, Gökçe Güllü Amuran, M. Ümit Uğurlu, Özkan Alan, Tuğba Akın Telli, Perran Fulden Yumuk, Mustafa Akkiprik
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Wiley 2024-01-01
Σειρά:	International Journal of Breast Cancer
Διαθέσιμο Online:	http://dx.doi.org/10.1155/2024/6117394

Παρόμοια τεκμήρια

New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins
ανά: Gökçe Güllü Amuran, κ.ά.
Έκδοση: (2018-12-01)

A simple and cost-effective real-time PCR method using diluted and heat-treated whole blood lysate
ανά: Gökçe Güllü Amuran, κ.ά.
Έκδοση: (2024-11-01)

The cfDNA in early cancer detection
ανά: Hussein Adil Abid, κ.ά.
Έκδοση: (2024-01-01)

Exploration of cfDNA landscape in NIPT and clinical utilities of cfDNA based gene expression inference in prenatal diagnostics
ανά: Ruo Jia, κ.ά.
Έκδοση: (2025-02-01)

Diagnostic Value of cfDNA in Pancreatic Cancer
ανά: XU Yijun, κ.ά.
Έκδοση: (2022-12-01)

Microfluidic Technologies for cfDNA Isolation and Analysis
ανά: Zheyun Xu, κ.ά.
Έκδοση: (2019-10-01)

cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
ανά: Elodie Bohers, κ.ά.
Έκδοση: (2021-06-01)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
ανά: Corinna Keup, κ.ά.
Έκδοση: (2022-03-01)

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
ανά: Stephen R. Fairclough, κ.ά.
Έκδοση: (2019-10-01)

Impact of Liquid Biopsy Preanalytics on cfDNA Fragmentation Analyses
ανά: A. Hallermayr, κ.ά.
Έκδοση: (2023-11-01)

What fraction of cellular DNA turnover becomes cfDNA?
ανά: Ron Sender, κ.ά.
Έκδοση: (2024-02-01)

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome
ανά: Laura Gerard, κ.ά.
Έκδοση: (2023-01-01)

Comparison of the source and prognostic utility of cfDNA in trauma and sepsis
ανά: Nicholas L. Jackson Chornenki, κ.ά.
Έκδοση: (2019-05-01)

Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond
ανά: Kavish Kohabir, κ.ά.
Έκδοση: (2021-04-01)

Somatic Mutation Calling from cfDNA Using Machine Learning
ανά: S. Akbarinejad, κ.ά.
Έκδοση: (2023-11-01)

Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
ανά: Jodie Wong, κ.ά.
Έκδοση: (2025-02-01)

Brave new world of cfDNA-omics for early cancer detection
ανά: Alessandro Russo, κ.ά.
Έκδοση: (2023-09-01)

Plasma cfDNA in Carcinoma of unknown primary: A case series
ανά: Rajat Thawani, κ.ά.
Έκδοση: (2024-03-01)

cfDNA Methylation Profiles and T-Cell Differentiation in Women with Endometrial Polyps
ανά: Xiao-Hong Li, κ.ά.
Έκδοση: (2022-12-01)

Use of Internal Standards to Develop Improved Methylation Detection in cfDNA
ανά: Erin L> Crawford
Έκδοση: (2023-05-01)

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
ανά: Leilei Liang, κ.ά.
Έκδοση: (2022-09-01)

Hypertensive disorders of pregnancy share common cfDNA methylation profiles
ανά: Marialuigia Spinelli, κ.ά.
Έκδοση: (2022-11-01)

The utility of cfDNA in TGCT patient management: a systematic review
ανά: Jure Krasic, κ.ά.
Έκδοση: (2022-05-01)

Deep cfDNA fragment end profiling enables cancer detection
ανά: Yulia V. Zhitnyuk, κ.ά.
Έκδοση: (2022-01-01)

The Prognostic and Predictive Value of DR-70 Immunoassay, A Novel Fibrin-Associated Biomarker, in Patients with Advanced Gastrointestinal Cancers
ανά: Tuğba AKIN TELLİ, κ.ά.
Έκδοση: (2022-03-01)

Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients
ανά: Yidan Ma, κ.ά.
Έκδοση: (2024-09-01)

Impact of cfDNA Input on Enzymatic Methylation Conversion and Library Preparation Robustness
ανά: U. Kunej, κ.ά.
Έκδοση: (2023-11-01)

Diagnostic Performance of Gene Expression and dd-cfDNA in Multiorgan Transplant Recipients
ανά: Ziad S. Zaky, MD, MBA, κ.ά.
Έκδοση: (2025-03-01)

Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker
ανά: Lucija Škara, κ.ά.
Έκδοση: (2023-01-01)

The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma
ανά: A-M Joëlle Marivel, κ.ά.
Έκδοση: (2023-01-01)

Evaluation of cfDNA as an early detection assay for dense tissue breast cancer
ανά: Mouadh Barbirou, κ.ά.
Έκδοση: (2022-05-01)

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.
ανά: Inga Medina Diaz, κ.ά.
Έκδοση: (2016-01-01)

Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors
ανά: Abbye E. McEwen, κ.ά.
Έκδοση: (2020-02-01)

Erratum to “The utility of cfDNA in TGCT patient management: a systematic review”
Έκδοση: (2022-06-01)

Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence.
ανά: Ryusaku Matsumoto, κ.ά.
Έκδοση: (2015-01-01)

Revisiting Telomere Shortening in Cancer
ανά: Keiji Okamoto, κ.ά.
Έκδοση: (2019-01-01)

Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review
ανά: Keerthi Ranganathan, κ.ά.
Έκδοση: (2024-09-01)

Plasma cfDNA VILL gene methylation as a diagnostic marker for nasopharyngeal carcinoma
ανά: Xiao-Yan Fu, κ.ά.
Έκδοση: (2025-02-01)

22: A case of partial trisomy 13 not detected on prenatal cfDNA screen
ανά: Laura Bryant, κ.ά.
Έκδοση: (2025-01-01)

Early detection of uterine corpus endometrial carcinoma utilizing plasma cfDNA fragmentomics
ανά: Jing Liu, κ.ά.
Έκδοση: (2024-07-01)